COVID-19

Showing NaN - NaN of 92

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acquiring Convalescent Specimens for COVID-19 Antibodies

Completed
  • COVID-19
  • +2 more
  • Blood draw
  • New York, New York
    Columbia University Irving Medical Center/NYP
Jul 18, 2022

SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +4 more
  • Athens, Alabama
  • +158 more
Jul 18, 2022

SARS-COV2 (COVID-19) Persistence After Convalescence

Recruiting
  • COVID-19
  • +2 more
    • New York, New York
      Columbia University Medical Center
    Jul 19, 2022

    COVID-19, COVID-19 Testing Trial in New York (Motivational interviewing (MI) counseling, Text messages (TMs) and quiz questions

    Recruiting
    • COVID-19
    • COVID-19 Testing
    • Motivational interviewing (MI) counseling
    • +3 more
    • New York, New York
      New York University Silver School of Social Work
    Jul 15, 2022

    COVID-19 Trial in New York (Nurse-Community-Family Partnership Intervention)

    Recruiting
    • COVID-19
    • Nurse-Community-Family Partnership Intervention
    • New York, New York
      New York University
    Jul 13, 2022

    COVID-19 Trial in Worldwide (SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1, SARS-CoV-2 recombinant protein

    Active, not recruiting
    • COVID-19
    • SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1
    • +10 more
    • Birmingham, Alabama
    • +71 more
    Jul 11, 2022

    COVID-19, Respiratory Failure, ARDS Trial in New York (Tenecteplase, Placebo)

    Completed
    • COVID-19
    • +2 more
    • New York, New York
      Mount Sinai Hospital
    Jul 6, 2022

    COVID-19 Vaccination and Breakthrough Infections Among Persons

    Completed
    • Immunocompromised
    • +5 more
    • BNT162b2 (Tozinameran)
    • New York, New York
      Pfizer Inc.
    Jul 1, 2022

    COVID-19 Trial in Worldwide (Baricitinib, Dexamethasone, Placebo)

    Completed
    • COVID-19
    • Birmingham, Alabama
    • +71 more
    Jun 22, 2022

    COVID-19 Trial in Phoenix, Baltimore, New York (Clazakizumab 25 mg, Clazakizumab 12.5 mg, Placebo)

    Completed
    • COVID-19
    • Clazakizumab 25 mg
    • +2 more
    • Phoenix, Arizona
    • +2 more
    Jun 10, 2022

    Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised Trial in Worldwide (DAS181, Placebo, DAS181 COVID-19)

    Recruiting
    • Lower Respiratory Tract Infection
    • +3 more
    • Duarte, California
    • +59 more
    Jun 3, 2022

    COVID-19 Trial in Worldwide (Remdesivir, RDV Placebo, Standard of Care)

    Terminated
    • COVID-19
    • Birmingham, Alabama
    • +62 more
    Jun 1, 2022

    COVID-19 Trial in Worldwide (Liquid Alpha1-Proteinase Inhibitor (Human), Placebo, Standard Medical Treatment)

    Terminated
    • COVID-19
    • Liquid Alpha1-Proteinase Inhibitor (Human)
    • +2 more
    • Birmingham, Alabama
    • +19 more
    Apr 12, 2022

    COVID-19, Acute Kidney Injury, Chronic Kidney Injury Trial in United States

    Recruiting
    • COVID-19
    • +2 more
      • New Haven, Connecticut
      • +4 more
      Apr 13, 2022

      Covid-19, Coronavirus Infection, Coronavirus Trial in New York (COVID-19 Serology, Health Care Worker Survey)

      Recruiting
      • Covid-19
      • +2 more
      • COVID-19 Serology
      • Health Care Worker Survey
      • New York, New York
        NewYork-Presbyterian Hosptial/Columbia University Irving Medical
      Apr 4, 2022

      COVID-19, Coronavirus, Coronavirus Infection Trial in United States (Convalescent Plasma, Saline solution)

      Active, not recruiting
      • COVID-19
      • +2 more
      • Convalescent Plasma
      • Saline solution
      • New Haven, Connecticut
      • +8 more
      Mar 30, 2022

      COVID, Covid-19, Coronavirus Trial in Brazil, United States (APL-9, Vehicle Control)

      Completed
      • COVID
      • +8 more
      • Fresno, California
      • +23 more
      Mar 21, 2022

      Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial in Worldwide (SNG001, Placebo)

      Completed
      • Severe Acute Respiratory Syndrome Coronavirus 2
      • COVID-19
      • Tucson, Arizona
      • +111 more
      Mar 2, 2022

      COVID-19 Trial in Worldwide (Placebo, Remdesivir)

      Completed
      • COVID-19
      • Birmingham, Alabama
      • +59 more
      Mar 9, 2022

      COVID-19 Trial in Worldwide (Interferon beta-1a, Placebo, Remdesivir)

      Completed
      • COVID-19
      • Interferon beta-1a
      • +2 more
      • Birmingham, Alabama
      • +63 more
      Mar 9, 2022

      COVID-19 Trial in Worldwide (Placebo, Remdesivir, Baricitinib)

      Completed
      • COVID-19
      • Placebo
      • +2 more
      • Birmingham, Alabama
      • +70 more
      Mar 9, 2022

      COVID-19 Trial in New York (Cohorting)

      Recruiting
      • COVID-19
      • Cohorting
      • New York, New York
      • +1 more
      Mar 7, 2022

      COVID-19 Trial in Brazil, Canada, United States (Convalescent plasma)

      Terminated
      • COVID-19
      • Convalescent plasma
      • Brooklyn, New York
      • +72 more
      Mar 1, 2022

      Corona Virus Infection, COVID-19, SARS Trial in New York (Zofin, Placebo)

      Active, not recruiting
      • Corona Virus Infection
      • +3 more
      • Zofin
      • Placebo
      • New York, New York
        George C. Shapiro
      Feb 2, 2022